The BioSim Ethics Commission has approved its position on the policies
of biological medicines and their implications for the patient, health professionals and the National Health System (NHS). To this end, it has drawn up a set of recommendations that includes the need to ensure clear and appropriate communication between health professionals and patients, as well as working on the training of managers and health professionals on biosimilar medicines.
recently published
